Sabra Health Care REIT Inc
F:SBC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sabra Health Care REIT Inc
F:SBC
|
US |
|
Natwest Group PLC
F:RYSD
|
UK |
|
C
|
Carrier Global Corp
F:4PN
|
US |
|
I
|
Intesa Sanpaolo SpA
XMUN:IES
|
IT |
|
P
|
Pfizer Inc
SIX:PFE
|
US |
|
John Wiley & Sons Inc
NYSE:WLY
|
US |
|
Z
|
Zimmer Biomet Holdings Inc
XMUN:ZIM
|
US |
|
T
|
Taylor Morrison Home Corp
F:THM
|
US |
|
S
|
Swire Pacific Ltd
OTC:SWRAY
|
HK |
Wall St Price Targets
SBC Price Targets Summary
Sabra Health Care REIT Inc
According to Wall Street analysts, the average 1-year price target for SBC is 19.803 EUR with a low forecast of 16.506 EUR and a high forecast of 22.579 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SBC's stock price target?
Price Target
19.803
EUR
According to Wall Street analysts, the average 1-year price target for SBC is 19.803 EUR with a low forecast of 16.506 EUR and a high forecast of 22.579 EUR.
What is the Revenue forecast for Sabra Health Care REIT Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 6 years is 12%.
What is the Operating Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 6 years is 13%.
What is the Pre-Tax Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 17%. The projected CAGR for the next 3 years is 13%.
What is the Net Income forecast for Sabra Health Care REIT Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 6 years is 14%.
